Expanding TCR Therapy Success by Pursuing Autoimmune Treatments
Time: 8:30 am
day: Day 2
Details:
• Taking learnings in TCR efficacy and safety from oncology and applying to optimize
• Evaluating your approach characteristics to determine the most suitable target indication
• Balancing durability and safety in non-oncology patient populations
